BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 8:11:25 AM | Browse: 635 | Download: 1254
 |
Received |
|
2021-01-12 14:37 |
|
Peer-Review Started |
|
2021-01-12 14:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-15 05:34 |
|
Revised |
|
2021-02-21 10:35 |
|
Second Decision |
|
2021-03-11 13:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-12 00:44 |
|
Articles in Press |
|
2021-03-12 00:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-19 01:32 |
|
Publish the Manuscript Online |
|
2021-04-09 08:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Nanotechnology and pancreatic cancer management: State of the art and further perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Damiano Caputo, Daniela Pozzi, Tommaso Farolfi, Roberto Passa, Roberto Coppola and Giulio Caracciolo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Damiano Caputo, FACS, MD, Associate Professor, Surgeon, Department of General Surgery, University Campus Bio-Medico di Roma, Via Álvaro del Portillo, 200, Rome 00128, Italy. d.caputo@unicampus.it |
| Key Words |
Pancreatic ductal adenocarcinoma; Biomarkers; Nanotechnology; Nanoparticles; Protein corona; Early detection |
| Core Tip |
Pancreatic ductal adenocarcinoma (PDAC) is very lethal. Surgery is the only effective treatment. Unfortunately, only 20% of PDACs can be radically resected because of the lack of tools for early diagnosis and since chemotherapy agents fail to reach satisfying prognosis. Nanoparticles can amplify the cancer-induced proteome alteration allowing early cancer detection and can also be used in cancer treatment as carriers improving the effectiveness of chemotherapy. This review focuses the actual and futures implications of nanotechnology in PDAC diagnosis and treatment. |
| Publish Date |
2021-04-09 08:11 |
| Citation |
Caputo D, Pozzi D, Farolfi T, Passa R, Coppola R, Caracciolo G. Nanotechnology and pancreatic cancer management: State of the art and further perspectives. World J Gastrointest Oncol 2021; 13(4): 231-237 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i4/231.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i4.231 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
